Pleasanton, CT, United States of America

Scott Godfrey

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Pleasanton, CT (US) (2019)
  • Pleasanton, CA (US) (2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Scott Godfrey: Innovating in Biological Product Manufacturing**

Introduction

Scott Godfrey, based in Pleasanton, Connecticut, is a notable inventor with a focus on innovations in biological product manufacturing. With three patents to his name, Godfrey is recognized for developing technologies that enhance the efficiency and effectiveness of biological processing systems.

Latest Patents

Among his latest inventions is the "Cell Retention Device and Method." This technology introduces a cell retention device designed for use in perfusion cell culture systems. It includes a hollow-fiber filter with an average pore size ranging from about 0.5 to about 20 μm. Remarkably, this device can operate under perfusion cell culture conditions for up to 35 days without becoming clogged or diminishing its product sieving ability by more than 20%.

Another significant patent is for "Methods, Apparatuses, and Systems for Continuously Inactivating a Virus During Manufacture of a Biological Product." This innovative method involves a sequence of steps that ensures continuous inactivation of viruses during the production of biological products. It includes combining a biological product composition with a virus-inactivation reagent, confirming its efficacy, and processing the treatment continuously through a specially designed vessel equipped with static mixers.

Career Highlights

Scott Godfrey works at Boehringer Ingelheim International GmbH, a company recognized for its dedication to advancing healthcare through innovative research and development in pharmaceuticals. His work focuses on enhancing manufacturing processes, addressing critical challenges in biological product formulation, and ensuring higher safety standards.

Collaborations

Throughout his career, Godfrey has collaborated with prominent coworkers such as Jonathan Coffman and Jeff Goby. These partnerships reflect a commitment to driving progress in the field of biological sciences, leveraging collective expertise to produce cutting-edge solutions.

Conclusion

Scott Godfrey stands out as a prominent inventor in the biopharmaceutical sector. His latest patents, focusing on advanced cell culture systems and virus inactivation methods, illustrate his dedication to improving biological product manufacturing. As he continues to work with industry leaders, like those at Boehringer Ingelheim, Godfrey’s contributions will likely play a crucial role in shaping the future of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…